ClinicalTrials.gov
public full text
Public Domain
Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008
The purpose of this study is to test the safety and immune response of a new intranasal vaccine against influenza, called NB-1008. The vaccine is composed of a licensed vaccine that is normally given as an injection, called Fluzone, and an adjuvant (additive that helps a vaccine work better), called W805EC.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older#127694
- Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults#234507
- Immunogenicity and Safety of Different Doses of Fluzone® Influenza#855837
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine#249663
- Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)#1010003
Record · ID 848116
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive